Literature DB >> 10509808

DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.

T Satoh1, T Monden, T Ishizuka, T Mitsuhashi, M Yamada, M Mori.   

Abstract

A negative thyroid hormone response element (TRE) in the mouse preprothyrotropin-releasing hormone (TRH) gene was previously mapped within the proximal promoter element between -83 and +53 that contained a TRE half-site motif at -57 (-57TGACCT-51). In transfection experiments, the promoter activity is stimulated by unliganded thyroid hormone receptor (TR) and T3 reverses the basal promoter stimulation. In this study, we determined whether the direct binding of TR to the TRE half-site in the mouse TRH gene is required for the ligand-independent stimulation using a transient transfection assay into CV-1 cells and electrophoretic mobility shift assays (EMSA). In addition, the role of a corepressor protein for the ligand-independent stimulation was examined using a putative splicing variant of the nuclear receptor corepressor (N-CoRI). Point mutations introduced into the TRE half-site at -57 eliminated the binding of TR and the stimulatory effect of unliganded TR. Two mutant TRs lacking DNA-binding activity and two CoR box mutant TRs showed no stimulation in the wild-type TRH promoter. The cotransfected N-CoRI potentiated the ligand-independent stimulation by the wild-type TR, but did not compensate for the impaired function of the CoR box mutant TR. In EMSA, TR strongly bound as homodimers and weakly as heterodimers with retinoid X receptor (RXR) to the element containing the TRE half-site at -57. Binding of TR to the TRE half-site was essential to form homo- and heterodimers, and the RXR binding site appeared to be located downstream of the TRE half-site. In vitro translated N-CoRI preferentially bound TR homodimers over TR/RXR heterodimers. These results collectively suggest that the DNA-bound TR/corepressor complex might be directly involved in the ligand-independent stimulation of the mouse TRH gene promoter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10509808     DOI: 10.1016/s0303-7207(99)00032-5

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor.

Authors:  Ryohei Umezawa; Masanobu Yamada; Kazuhiko Horiguchi; Sumiyasu Ishii; Koshi Hashimoto; Shuichi Okada; Teturou Satoh; Masatomo Mori
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

2.  E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode.

Authors:  Xianwang Meng; Paul Webb; Yong-Fan Yang; Michael Shuen; Ahmed F Yousef; John D Baxter; Joe S Mymryk; Paul G Walfish
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

3.  The thyrotropin-releasing hormone gene is regulated by thyroid hormone at the level of transcription in vivo.

Authors:  Michelle L Sugrue; Kristen R Vella; Crystal Morales; Marisol E Lopez; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2009-12-23       Impact factor: 4.736

4.  To bind or not to bind - how to down-regulate target genes by liganded thyroid hormone receptor?

Authors:  Joachim M Weitzel
Journal:  Thyroid Res       Date:  2008-10-11

5.  Identification of thyroid hormone receptor binding sites in developing mouse cerebellum.

Authors:  Remi Gagne; James R Green; Hongyan Dong; Mike G Wade; Carole L Yauk
Journal:  BMC Genomics       Date:  2013-05-23       Impact factor: 3.969

Review 6.  Integrating Thyroid Hormone Signaling in Hypothalamic Control of Metabolism: Crosstalk Between Nuclear Receptors.

Authors:  Soumaya Kouidhi; Marie-Stéphanie Clerget-Froidevaux
Journal:  Int J Mol Sci       Date:  2018-07-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.